Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
If future research cements GLP-1s cardiovascular advantages, it would further strengthen the rationale for their use in at-risk patients beyond just encouraging weight reduction.(38) However, outcome trials in non-diabetic people taking GLP-1 drugs for obesity alone are still needed to clarify precise cardiovascular implications in this context.(39) How Do GLP-1 Drugs Affect Type 2 Diabetes
COA transparency Look for batch, purity, and identity verification where available
Midany, B
Here are some key points about Mounjaros effectiveness: Higher Weight Loss : Clinical trials revealed that Mounjaro participants lost an average of 18.4% of their body weight compared to 14.9% with Wegovy and 15% with Ozempic, marking a significant new weight loss breakthrough
Indications & practical tips Both substances are suitable for patients with obesity (BMI 30 ) or overweight (BMI 27 + concomitant diseases ) suitable
